MS
EW icon

Maven Securities’s Edwards Lifesciences EW Stock Holding History

Maven Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,941
Closed -$218K – 856
2024
Q4 		$218K Buy
+2,941
New +$206K 0.01% 761
2024
Q2 		– Sell
-10,000
Closed -$886K – 930
2024
Q1 		$956K Buy
+10,000
New +$840K 0.06% 148
2021
Q4 		– Sell
-2,567
Closed -$299K – 933
2021
Q3 		$291K Buy
+2,567
New +$293K 0.01% 842
2021
Q1 		– Sell
-17,000
Closed -$1.44M – 1204
2020
Q4 		$1.55M Buy
+17,000
New +$1.41M 0.15% 170

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Maven Securities's EW Position: Q1 2025 in Review

Maven Securities sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 2,941 shares — an estimated $218K sold.

Maven Securities first reported a position in EW in Q4 2020 and held it in 4 quarters. The position peaked at $1.55M in Q4 2020. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Maven Securities reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 2,941 Edwards Lifesciences shares in Q1 2025, an estimated $218K.
  • Maven Securities first reported a position in Edwards Lifesciences in Q4 2020 and held it in 4 quarters.
  • Maven Securities's Edwards Lifesciences position peaked at $1.55M in Q4 2020.
  • 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.